Anna M. Rydzik
Impact in
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotic Resistance in Bacteria 15
-
- Metabolism and Genetic Disorders 10
- Co-authors
- Christopher J. SchofieldTimothy D. W. ClaridgeJürgen BremJacek JemielityJoanna KowalskaEdward DarżynkiewiczSander S. van BerkelM.A. McDonough
- Journals
- Antimicrobial Agents and Chemotherapy (3 papers)Angewandte Chemie International Edition (3 papers)Chemical Communications (2 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)Organic & Biomolecular Chemistry (2 papers)
- Partner nations
- United KingdomPolandUnited States
In The Last Decade
Anna M. Rydzik
42 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 84
- Molecular Medicine 425
- Applied Microbiology and Biotechnology 48
- Pharmacology 212
- Cancer Research 137
- Clinical Biochemistry 61
Countries citing papers authored by Anna M. Rydzik
This map shows the geographic impact of Anna M. Rydzik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna M. Rydzik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna M. Rydzik more than expected).
Fields of papers citing papers by Anna M. Rydzik
This network shows the impact of papers produced by Anna M. Rydzik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna M. Rydzik. The network helps show where Anna M. Rydzik may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Anna M. Rydzik, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 16 | |
| 2 | 2023 | 3 | |
| 3 | 2023 | 1 | |
| 4 | 2017 | 28 | |
| 5 | 2016 | 12 | |
| 6 | 2016 | 19 | |
| 7 | 2014 | 4 | |
| 8 | 2014 | 56 | |
| 9 | 2014 | 66 | |
| 10 | 2014 | 10 | |
| 11 | 2014 | 1 | |
| 12 | 2014 | 21 | |
| 13 | 2014 | 8 | |
| 14 | 2014 | 101 | |
| 15 | 2013 | 21 | |
| 16 | 2012 | 24 | |
| 17 | 2011 | 49 | |
| 18 | 2010 | 62 | |
| 19 | 2009 | 51 | |
| 20 | 2008 | 1 |
About Anna M. Rydzik
Anna M. Rydzik is a scholar working on Molecular Medicine, Clinical Biochemistry, Applied Microbiology and Biotechnology, Pharmacology and Molecular Biology, having authored 42 papers that have together received 1.1k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (15 papers), Metabolism and Genetic Disorders (10 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers), Metabolomics and Mass Spectrometry Studies (6 papers), Mitochondrial Function and Pathology (6 papers), RNA modifications and cancer (6 papers), RNA and protein synthesis mechanisms (6 papers) and Tuberculosis Research and Epidemiology (5 papers). The work is most often cited by research in Molecular Medicine (425 citations), Applied Microbiology and Biotechnology (48 citations), Pharmacology (212 citations), Cancer Research (137 citations) and Clinical Biochemistry (61 citations). Anna M. Rydzik has collaborated with scholars based in United Kingdom, Poland and United States. Frequent co-authors include Christopher J. Schofield, Timothy D. W. Claridge, Jürgen Brem, Jacek Jemielity, Joanna Kowalska, Edward Darżynkiewicz, Sander S. van Berkel, M.A. McDonough, James Spencer and Ivanhoe K. H. Leung. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Angewandte Chemie International Edition, Chemical Communications, Bioorganic & Medicinal Chemistry Letters and Organic & Biomolecular Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.